Archive for November 30th, 2009
Title: Cysticercosis
Category: Diseases and Conditions
Created: 11/25/2009 10:33:00 AM
Last Editorial Review: 11/25/2009 10:33:41 AM
Limitations in therapy induced by adverse effects due to unselective drug availability and therefore the use of potentially too high doses are a common problem. One prominent example for this dilemma are inflammatory diseases…
The MS Society was invited in to the House of Commons this week to share the views of people affected by MS with the Health Select Committee as part of their inquiry into the future of the social care system. The inquiry follows the Government’s Green Paper published earlier this year on which the Society provided extensive feedback…
Limitations in therapy induced by adverse effects due to unselective drug availability and therefore the use of potentially too high doses are a common problem. One prominent example for this dilemma are inflammatory diseases…
The MS Society was invited in to the House of Commons this week to share the views of people affected by MS with the Health Select Committee as part of their inquiry into the future of the social care system. The inquiry follows the Government’s Green Paper published earlier this year on which the Society provided extensive feedback…
ABOUT
Your online resource center for Multiple Sclerosis Information
RECENT POSTS
Best Selling Book
Subscriptions
RSSContributors
Archives
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008